Tuberculosis (TB) remains a critical public health issue in Africa, where antimicrobial resistance (AMR) is severely impacting TB treatment effectiveness, leading to increased morbidity and mortality. This research examines the prevalence of TB in Africa, the rising rates of AMR in TB strains, and the primary drivers behind these trends. Through an analysis of socio-economic factors, healthcare infrastructure challenges, and the misuse of antibiotics, this study provides insight into the factors contributing to AMR in TB. Furthermore, this research explores interventions to reduce AMR and improve TB treatment outcomes, including policy reforms, improved diagnostics, and increased funding for healthcare and public awareness initiatives. Findings underscore the urgent need for a coordinated approach to managing AMR in TB to mitigate the public health risks facing African nations.
Tuberculosis (TB), Antimicrobial Resistance (AMR), Mortality, Healthcare.
IRE Journals:
Adewale Adeboye Adewole , Samuel Paul Gyamfi , Jesseline Mwinila Eledi
"Antimicrobial Resistance and Tuberculosis Prevalence in Africa: A Public Health Concern" Iconic Research And Engineering Journals Volume 8 Issue 5 2024 Page 755-765
IEEE:
Adewale Adeboye Adewole , Samuel Paul Gyamfi , Jesseline Mwinila Eledi
"Antimicrobial Resistance and Tuberculosis Prevalence in Africa: A Public Health Concern" Iconic Research And Engineering Journals, 8(5)